SNNSmith & Nephew plc

$29.30

$29.0552 weeks$37.81

Price

$29.30-17%1Y

1M-1.6%1Y-17%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Not rated

Not enough fundamentals to score this one.

What they do

Smith & Nephew plc (the “Company”) is a public limited company incorporated in England and Wales. In these accounts, the ‘Group’ means the Company and all its subsidiaries. The principal activities of the Group are to develop, manufacture, market and sell medical devices and services. The Group has prepared its accounts in accordance with UK-adopted International Accounting Standards. The Group has also prepared its accounts in accordance with IFRS Accounting Standards as issued by the International Accounting Standards Board (IASB) effective as at 31 December 2025.

In the company’s own words · 20-F filed Mar 16, 2026 · SEC EDGAR

P/E (TTM)40.9

Market Cap$12.74B

1Y Return-17%

5Y Return-16%

For the full year FY2025, revenue was $6.16B (+6.1% year on year) and net income $625M.